Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07311850) titled 'Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity' on Dec. 29, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Metsera
Condition:
Obesity and Overweight
Intervention:
Drug: MET097
Recruitment Status: Recruiting
Phase: Phase 3
Date of First Enrollment: December 29, 2025
Target Sample Size: 3500
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07311850
Published by HT Digital ...